Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 192


Human apolipoprotein A-II protects against diet-induced atherosclerosis in transgenic rabbits.

Wang Y, Niimi M, Nishijima K, Waqar AB, Yu Y, Koike T, Kitajima S, Liu E, Inoue T, Kohashi M, Keyamura Y, Yoshikawa T, Zhang J, Ma L, Zha X, Watanabe T, Asada Y, Chen YE, Fan J.

Arterioscler Thromb Vasc Biol. 2013 Feb;33(2):224-31. doi: 10.1161/ATVBAHA.112.300445. Epub 2012 Dec 13.


Hydrogen decreases athero-susceptibility in apolipoprotein B-containing lipoproteins and aorta of apolipoprotein E knockout mice.

Song G, Tian H, Qin S, Sun X, Yao S, Zong C, Luo Y, Liu J, Yu Y, Sang H, Wang X.

Atherosclerosis. 2012 Mar;221(1):55-65. doi: 10.1016/j.atherosclerosis.2011.11.043. Epub 2011 Dec 13.


Omega-3 fatty acids ameliorate atherosclerosis by favorably altering monocyte subsets and limiting monocyte recruitment to aortic lesions.

Brown AL, Zhu X, Rong S, Shewale S, Seo J, Boudyguina E, Gebre AK, Alexander-Miller MA, Parks JS.

Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2122-30. doi: 10.1161/ATVBAHA.112.253435. Epub 2012 Jul 19.


Expression of human apoAII in transgenic rabbits leads to dyslipidemia: a new model for combined hyperlipidemia.

Koike T, Kitajima S, Yu Y, Li Y, Nishijima K, Liu E, Sun H, Waqar AB, Shibata N, Inoue T, Wang Y, Zhang B, Kobayashi J, Morimoto M, Saku K, Watanabe T, Fan J.

Arterioscler Thromb Vasc Biol. 2009 Dec;29(12):2047-53. doi: 10.1161/ATVBAHA.109.190264. Epub 2009 Sep 24. Erratum in: Arterioscler Thromb Vasc Biol. 2010 May;30(5):1069.


Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.

Ribas V, Sánchez-Quesada JL, Antón R, Camacho M, Julve J, Escolà-Gil JC, Vila L, Ordóñez-Llanos J, Blanco-Vaca F.

Circ Res. 2004 Oct 15;95(8):789-97. Epub 2004 Sep 23.


AIP1 suppresses atherosclerosis by limiting hyperlipidemia-induced inflammation and vascular endothelial dysfunction.

Huang Q, Qin L, Dai S, Zhang H, Pasula S, Zhou H, Chen H, Min W.

Arterioscler Thromb Vasc Biol. 2013 Apr;33(4):795-804. doi: 10.1161/ATVBAHA.113.301220. Epub 2013 Feb 14.


Transgenic rabbits expressing human apolipoprotein(a) develop more extensive atherosclerotic lesions in response to a cholesterol-rich diet.

Fan J, Shimoyamada H, Sun H, Marcovina S, Honda K, Watanabe T.

Arterioscler Thromb Vasc Biol. 2001 Jan;21(1):88-94.


Attenuation of early atherogenesis in low-density lipoprotein receptor-deficient mice by proteasome inhibition.

Wilck N, Fechner M, Dreger H, Hewing B, Arias A, Meiners S, Baumann G, Stangl V, Stangl K, Ludwig A.

Arterioscler Thromb Vasc Biol. 2012 Jun;32(6):1418-26. doi: 10.1161/ATVBAHA.112.249342. Epub 2012 Apr 19.


Overexpression of angiopoietin-like protein 4 protects against atherosclerosis development.

Georgiadi A, Wang Y, Stienstra R, Tjeerdema N, Janssen A, Stalenhoef A, van der Vliet JA, de Roos A, Tamsma JT, Smit JW, Tan NS, Müller M, Rensen PC, Kersten S.

Arterioscler Thromb Vasc Biol. 2013 Jul;33(7):1529-37. doi: 10.1161/ATVBAHA.113.301698. Epub 2013 May 2.


P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice.

Stachon P, Peikert A, Michel NA, Hergeth S, Marchini T, Wolf D, Dufner B, Hoppe N, Ayata CK, Grimm M, Cicko S, Schulte L, Reinöhl J, von zur Muhlen C, Bode C, Idzko M, Zirlik A.

Arterioscler Thromb Vasc Biol. 2014 Oct;34(10):2237-45. doi: 10.1161/ATVBAHA.114.303585. Epub 2014 Aug 7.


MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosis.

Meiler S, Baumer Y, Toulmin E, Seng K, Boisvert WA.

Arterioscler Thromb Vasc Biol. 2015 Feb;35(2):323-31. doi: 10.1161/ATVBAHA.114.304878. Epub 2014 Dec 18.


Plasmacytoid dendritic cells play a key role in promoting atherosclerosis in apolipoprotein E-deficient mice.

Macritchie N, Grassia G, Sabir SR, Maddaluno M, Welsh P, Sattar N, Ialenti A, Kurowska-Stolarska M, McInnes IB, Brewer JM, Garside P, Maffia P.

Arterioscler Thromb Vasc Biol. 2012 Nov;32(11):2569-79. doi: 10.1161/ATVBAHA.112.251314. Epub 2012 Aug 30.


Protective role for Toll-like receptor-9 in the development of atherosclerosis in apolipoprotein E-deficient mice.

Koulis C, Chen YC, Hausding C, Ahrens I, Kyaw TS, Tay C, Allen T, Jandeleit-Dahm K, Sweet MJ, Akira S, Bobik A, Peter K, Agrotis A.

Arterioscler Thromb Vasc Biol. 2014 Mar;34(3):516-25. doi: 10.1161/ATVBAHA.113.302407. Epub 2014 Jan 16.


Worsening of diet-induced atherosclerosis in a new model of transgenic rabbit expressing the human plasma phospholipid transfer protein.

Masson D, Deckert V, Gautier T, Klein A, Desrumaux C, Viglietta C, Pais de Barros JP, Le Guern N, Grober J, Labbé J, Ménétrier F, Ripoll PJ, Leroux-Coyau M, Jolivet G, Houdebine LM, Lagrost L.

Arterioscler Thromb Vasc Biol. 2011 Apr;31(4):766-74. doi: 10.1161/ATVBAHA.110.215756. Epub 2011 Jan 20.


KRP-203, sphingosine 1-phosphate receptor type 1 agonist, ameliorates atherosclerosis in LDL-R-/- mice.

Potì F, Gualtieri F, Sacchi S, Weißen-Plenz G, Varga G, Brodde M, Weber C, Simoni M, Nofer JR.

Arterioscler Thromb Vasc Biol. 2013 Jul;33(7):1505-12. doi: 10.1161/ATVBAHA.113.301347. Epub 2013 May 2.


Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I-transgenic rabbits.

Duverger N, Kruth H, Emmanuel F, Caillaud JM, Viglietta C, Castro G, Tailleux A, Fievet C, Fruchart JC, Houdebine LM, Denefle P.

Circulation. 1996 Aug 15;94(4):713-7.


Interleukin 27 inhibits atherosclerosis via immunoregulation of macrophages in mice.

Hirase T, Hara H, Miyazaki Y, Ide N, Nishimoto-Hazuku A, Fujimoto H, Saris CJ, Yoshida H, Node K.

Am J Physiol Heart Circ Physiol. 2013 Aug 1;305(3):H420-9. doi: 10.1152/ajpheart.00198.2013. Epub 2013 May 31.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk